Dr Reddys Laboratories (RDY) Debt to Equity (2022 - 2025)
Dr Reddys Laboratories (RDY) has 3 years of Debt to Equity data on record, last reported at $0.03 in Q1 2024.
- For Q1 2024, Debt to Equity fell 1.22% year-over-year to $0.03; the TTM value through Mar 2024 reached $0.03, down 1.22%, while the annual FY2024 figure was $0.03, 1.2% up from the prior year.
- Debt to Equity reached $0.03 in Q1 2024 per RDY's latest filing, down from $0.03 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.17 in Q1 2022 and bottomed at $0.03 in Q1 2024.
- Average Debt to Equity over 3 years is $0.07, with a median of $0.03 recorded in 2023.
- Peak YoY movement for Debt to Equity: plummeted 84.72% in 2023, then dropped 1.22% in 2024.
- A 3-year view of Debt to Equity shows it stood at $0.17 in 2022, then tumbled by 84.72% to $0.03 in 2023, then decreased by 1.22% to $0.03 in 2024.
- Per Business Quant database, its latest 3 readings for Debt to Equity were $0.03 in Q1 2024, $0.03 in Q1 2023, and $0.17 in Q1 2022.